Ventripoint is pleased to announce that @LucMertens8, Head of of Echocardiography at @SickKidsNews, has joined the Ventripoint Clinical Advisory Board. Welcome @LucMertens8 !
Happy to report that Canada HealthWatch today published a White Paper on how Ventripoint is putting the heart into AI
CanadaHealthWatch.ca
Check out Ventripoint’s feature as one of the top emerging medical technology stocks for 2024 from @digitaljournal tinyurl.com/4yuacvv8
Ventripoint is now a part of @ASCENDCV global distribution and marketing for cardiac diagnostic and imaging technologies. Ventripoint’s AI-powered diagnostic technology will be integrated into Ascend’s IT for cardiovascular care for its current user base of over 50,000 hospitals.
Ventripoint had two successful days at #BSEcho2023 with discussions on #cardiovasuclar research and live demonstrations with the VMS+. Thank you to @BSEcho for organizing a fantastic event!
Ventripoint is a proud sponsor of the European Echocardiography Course on Congenital Heart Disease that just had its latest meeting in Prague. Ventripoint is committed to improving CHD diagnosis and treatment as part of the global echo community. #CHD
Ventripoint will be exhibiting its VMS+ cardiac diagnostic tool at the 51st Annual Nordic Paediatric Meeting on September 13-15 in Helsinki. We can’t wait to connect with other cardiac professionals in the Nordic region! @FinCardio #CHD #echocardiography
Ventripoint will be a Gold Sponsor for the 8th Annual All-Florida Pediatric Echo Society Symposium tomorrow, September 9th! Join us in advancing pediatric cardiac care with @AdventHealthCFL #CHD
Join us on August 30th at the @8thWCPCCS2023 for a digital transformation experience. We will be demonstrating how to use the VMS+ software and show how easy it is to construct a 3D model from a 2D echo. #echocardiography #cardiac #CHD
Ventripoint joins forces with @ASCENDCV to enhance cardiovascular diagnostics and patient care. This collaboration will bring innovative and exciting solutions in the cardiovascular field. #CHD #cardiology
Ventripoint Diagnostics is thrilled to participate in the 8th World Congress of Paediatric Cardiology & Cardiac Surgery @8thWCPCCS2023, discussing all things #cardiacimaging #CHD and more
Freiburg Hospital has chosen to adopt the VMS+ 3.0 as a part of their day-to-day diagnostic procedures. This exciting partnership will improve the patient experience as well as clinical outcomes. #chd #cardiology #echo
Ventripoint is proud to sponsor Advanced Imaging 2023: Pericardial Disease, a prestigious conference organized by @BSEcho & @RoySocMed. Join us July 18, 2023 in London for a comprehensive overview of multimodality imaging & intervention in pericardial disease #advancedimaging2023
Dr Laser speaks on how Ventripoint’s Knowledge Based Reconstruction (KBR) can analyze cMRI and RT3DE images in only 5 minutes during AEPC 23:
German Heart Centre Berlin has announced its purchase of Ventripoint’s VMS+ 3.0. We are looking forward to seeing this partnership improve efficiency and patient management within the congenital heart disease department.
Check out some highlights from Dr Laser’s talk at AEPC 23 detailing the accuracy of VMS 3.0 in a TOF study at Sick Kids, Toronto:
Ventripoint had an exciting weekend at Echo In the Nations Capital. We were honoured to be a part of the event, discussing new trends in #echocardiography. Thank you to everyone who stopped by the Ventripoint booth & Echo in the Nations Capital for a great conference!
